THE DEMONSTRATION OF AN INHIBITOR OF ONCOLYSIS IN THE ASCITIC FLUID FROM THE EHRLICH ASCITES CARCINOMA
1964
Inhibitor of Oncolysis in Ehrlich Ascites Carcinoma Fluid
publication
Author Information
Author(s): F. Hartveit
Primary Institution: Gade Institute, Department of Pathology, University of Bergen
Hypothesis
The study investigates whether an inhibitor of lysis is present in the ascitic fluid from the Ehrlich ascites carcinoma.
Conclusion
The study demonstrates that the ascitic fluid from the Ehrlich ascites carcinoma has a significant inhibitory effect on the oncolytic activity of human serum.
Supporting Evidence
- The study shows that the inhibitory effect of ascitic fluid increases with the age of the tumor transplant.
- The ascitic fluid was effective at both 20 and 37 degrees Celsius.
- The presence of an inhibitor of lysis was confirmed in the ascitic fluid.
Takeaway
The fluid from a type of cancer can stop the body's ability to kill cancer cells, especially as the cancer grows older.
Methodology
The study tested the effect of tumor ascitic fluid on the oncolytic reaction in vitro using human serum and tumor cells from different transplant ages.
Want to read the original?
Access the complete publication on the publisher's website